Recombinant l-phenylalanine ammonia lyase from Rhodosporidium toruloides as a potential anticancer agent

Biotechnol Appl Biochem. 2013 May-Jun;60(3):316-22. doi: 10.1002/bab.1089. Epub 2013 May 29.

Abstract

The recombinant producer strain expressing Rhodosporidium toruloides l-phenylalanine ammonia lyase (PAL) has been obtained, and a purification procedure of PAL has been developed. The purified enzyme, PAL, has the following biochemical and catalytic characteristics: Km for l-Phe of 0.49 mM, pH optimum at 8.5, and temperature optimum at 50°C. PAL exhibited a significant cytotoxic effect toward the following cell lines: MCF7 (IC50 = 1.97 U/mL), DU145 (IC50 = 7.3 U/mL), which are comparable with E. coli l-asparaginase type-II cytotoxicity in vitro. Administration of PAL (200-400 U/kg) to L5178y-bearing mice for five times (a total dose of 1000-2000 U/kg) was well tolerated and showed the increase of life span (ILS) = 12-16%, P < 0.05. Data obtained suggest that PAL from R. toruloides has a potential for cancer treatment.

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Female
  • Humans
  • Hydrogen-Ion Concentration
  • MCF-7 Cells
  • Mice
  • Phenylalanine Ammonia-Lyase / genetics*
  • Phenylalanine Ammonia-Lyase / pharmacology*
  • Recombinant Proteins / genetics*
  • Recombinant Proteins / pharmacology*
  • Temperature
  • Yeasts / genetics
  • Yeasts / metabolism

Substances

  • Antineoplastic Agents
  • Recombinant Proteins
  • Phenylalanine Ammonia-Lyase